Minqi Xiong
110 Ganhe Rd
Shanghai, 200437, China
Shanghai, 200437, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Ginsenoside Rb1 mitigates atherosclerosis in part through modulating FTO-mediated m6A RNA modification in NETs-induced endothelial activation.
Journal: Frontiers in pharmacology
Published: May 19, 2025
Dengyinnaotong attenuates atherosclerotic lesions, gut dysbiosis and intestinal epithelial barrier impairment in the high fat diet-fed ApoE-/- mice.
Journal: Journal of ethnopharmacology
Published: April 27, 2023
Dual Activity of Ginsenoside Rb1 in Hypertrophic Cardiomyocytes and Activated Macrophages: Implications for the Therapeutic Intervention of Cardiac Hypertrophy.
Journal: Journal of inflammation research
Published: March 12, 2021
Shexiang Tongxin dropping pill attenuates atherosclerotic lesions in ApoE deficient mouse model.
Journal: Journal of ethnopharmacology
Published: June 30, 2014
Apocynin attenuates isoproterenol-induced myocardial injury and fibrogenesis.
Journal: Biochemical and biophysical research communications
Published: April 25, 2014
MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation.
Journal: International journal of cardiology
Published: April 16, 2014
Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse model.
Journal: PloS one
Published: April 08, 2014
Bidirectional regulation of angiogenesis and miR-18a expression by PNS in the mouse model of tumor complicated by myocardial ischemia.
Journal: BMC complementary and alternative medicine
Published: January 13, 2014
Panax notoginseng saponins (PNS) inhibits breast cancer metastasis.
Journal: Journal of ethnopharmacology
Published: October 21, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026